{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:05:09Z","timestamp":1761919509522},"reference-count":65,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2012,1,5]],"date-time":"2012-01-05T00:00:00Z","timestamp":1325721600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1002475","type":"journal-article","created":{"date-parts":[[2012,1,6]],"date-time":"2012-01-06T09:02:02Z","timestamp":1325840522000},"page":"e1002475","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":30,"title":["Antibody Inhibition of a Viral Type 1 Interferon Decoy Receptor Cures a Viral Disease by Restoring Interferon Signaling in the Liver"],"prefix":"10.1371","volume":"8","author":[{"given":"Ren-Huan","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Rubio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felicia","family":"Roscoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracy E.","family":"Krouse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Ellen","family":"Truckenmiller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher C.","family":"Norbury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul N.","family":"Hudson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inger K.","family":"Damon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Alcam\u00ed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis J.","family":"Sigal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2012,1,5]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1146\/annurev.immunol.23.021704.115843","article-title":"Type I interferons (alpha\/beta) in immunity and autoimmunity.","volume":"23","author":"AN Theofilopoulos","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"ref2","article-title":"Fields' Virology.4th edition.","year":"2001"},{"key":"ref3","article-title":"Principles of virology.","author":"SJ Flint","year":"2009"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/0092-8674(95)90076-4","article-title":"Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity.","volume":"81","author":"JA Symons","year":"1995","journal-title":"Cell"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1128\/JVI.76.3.1124-1134.2002","article-title":"Inhibition of interferons by ectromelia virus.","volume":"76","author":"VP Smith","year":"2002","journal-title":"J Virol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1096\/fj.09-144733","article-title":"The highly virulent variola and monkeypox viruses express secreted inhibitors of type I interferon.","volume":"24","author":"M Fernandez de Marco Mdel","year":"2010","journal-title":"FASEB J"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"15974","DOI":"10.1074\/jbc.270.27.15974","article-title":"Vaccinia virus B18R gene encodes a type I interferon-binding protein that blocks interferon alpha transmembrane signaling.","volume":"270","author":"OR Colamonici","year":"1995","journal-title":"J Biol Chem"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/0042-6822(90)90524-U","article-title":"Identification and nucleotide sequence of the gene encoding a surface antigen induced by vaccinia virus.","volume":"177","author":"Y Ueda","year":"1990","journal-title":"Virology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1073\/pnas.0711573105","article-title":"Kinetic analysis of a complete poxvirus transcriptome reveals an immediate-early class of genes.","volume":"105","author":"E Assarsson","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1084\/jem.20071854","article-title":"The orthopoxvirus type I IFN binding protein is essential for virulence and an effective target for vaccination.","volume":"205","author":"RH Xu","year":"2008","journal-title":"J Exp Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/nri891","article-title":"Antibodies, viruses and vaccines.","volume":"2","author":"DR Burton","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.antiviral.2009.08.008","article-title":"Wanted, dead or alive: new viral vaccines.","volume":"84","author":"IJ Amanna","year":"2009","journal-title":"Antiviral Res"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"12355","DOI":"10.1128\/JVI.01593-09","article-title":"Heavily isotype-dependent protective activities of human antibodies against vaccinia virus extracellular virion antigen B5.","volume":"83","author":"MR Benhnia","year":"2009","journal-title":"J Virol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/0264-410X(92)90106-T","article-title":"Bacterial vaccines: old and new, veterinary and medical.","volume":"10","author":"PD Walker","year":"1992","journal-title":"Vaccine"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri980","article-title":"Viral mimicry of cytokines, chemokines and their receptors.","volume":"3","author":"A Alcami","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"ref16","first-page":"335","article-title":"Pathogenesis of viral infection.","author":"HW Virgin","year":"2007"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"341","DOI":"10.4049\/jimmunol.63.4.341","article-title":"Mouse-pox; infectious ectromelia of mice; a review.","volume":"63","author":"F Fenner","year":"1949","journal-title":"J Immunol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/301527a0","article-title":"A severe combined immunodeficiency mutation in the mouse.","volume":"301","author":"GC Bosma","year":"1983","journal-title":"Nature"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"11230","DOI":"10.1128\/JVI.74.23.11230-11239.2000","article-title":"The vaccinia virus soluble alpha\/beta interferon (IFN) receptor binds to the cell surface and protects cells from the antiviral effects of IFN.","volume":"74","author":"A Alcami","year":"2000","journal-title":"J Virol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1084\/jem.185.8.1493","article-title":"Anti-CD43 inhibition of T cell homing.","volume":"185","author":"LM McEvoy","year":"1997","journal-title":"J Exp Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/0022-2836(89)90107-1","article-title":"Structure of vaccinia virus early promoters.","volume":"210","author":"AJ Davison","year":"1989","journal-title":"J Mol Biol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.1128\/JVI.72.5.4192-4204.1998","article-title":"The envelope protein encoded by the A33R gene is required for formation of actin-containing microvilli and efficient cell-to-cell spread of vaccinia virus.","volume":"72","author":"RL Roper","year":"1998","journal-title":"J Virol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nri2206","article-title":"Fcgamma receptors as regulators of immune responses.","volume":"8","author":"F Nimmerjahn","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0065-2776(01)77018-6","article-title":"The antiviral activity of antibodies in vitro and in vivo.","volume":"77","author":"P Parren","year":"2001","journal-title":"Adv Immunol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1006\/viro.1997.8527","article-title":"Analysis of an interaction between the soluble vaccinia virus-coded type I interferon (IFN)-receptor and human IFN-alpha1 and IFN-alpha2.","volume":"232","author":"H Liptakova","year":"1997","journal-title":"Virology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1084\/jem.194.9.1361","article-title":"Inflammatory chemokine transport and presentation in HEV: a remote control mechanism for monocyte recruitment to lymph nodes in inflamed tissues.","volume":"194","author":"RT Palframan","year":"2001","journal-title":"J Exp Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/ni.f.214","article-title":"Chemokines and leukocyte traffic.","volume":"9","author":"F Sallusto","year":"2008","journal-title":"Nat Immunol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/ni.f.207","article-title":"How chemokines invite leukocytes to dance.","volume":"9","author":"M Thelen","year":"2008","journal-title":"Nat Immunol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/ng0501-42","article-title":"Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily.","volume":"28","author":"SH Lee","year":"2001","journal-title":"Nat Genet"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0022-1759(90)90049-2","article-title":"The in vitro lymphocyte\/endothelium binding assay. An improved method employing light microscopy.","volume":"130","author":"KU Willfuhr","year":"1990","journal-title":"J Immunol Methods"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1034\/j.1600-065X.2000.917309.x","article-title":"Innate immune recognition: mechanisms and pathways.","volume":"173","author":"R Medzhitov","year":"2000","journal-title":"Immunol Rev"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1371\/journal.ppat.0040030","article-title":"A role for NKG2D in NK cell-mediated resistance to poxvirus disease.","volume":"4","author":"M Fang","year":"2008","journal-title":"PLoS Pathog"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1084\/jem.20100282","article-title":"Age-dependent susceptibility to a viral disease due to decreased natural killer cell numbers and trafficking.","volume":"207","author":"M Fang","year":"2010","journal-title":"J Exp Med"},{"key":"ref34","article-title":"Immunobiology: the immune system in health and disease.","author":"C Janeway","year":"2005"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"10992","DOI":"10.1073\/pnas.0701822104","article-title":"Memory CD8+ T cells are gatekeepers of the lymph node draining the site of viral infection.","volume":"104","author":"R-H Xu","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1146\/annurev.immunol.21.120601.141049","article-title":"Poxviruses and immune evasion.","volume":"21","author":"BT Seet","year":"2003","journal-title":"Annu Rev Immunol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1126\/science.280.5361.248","article-title":"Viral strategies of immune evasion.","volume":"280","author":"HL Ploegh","year":"1998","journal-title":"Science"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0966-842X(00)01830-8","article-title":"Viral mechanisms of immune evasion.","volume":"8","author":"A Alcami","year":"2000","journal-title":"Trends Microbiol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.mib.2010.07.001","article-title":"The interaction of viruses with host immune defenses.","volume":"13","author":"A Alcami","year":"2010","journal-title":"Curr Opin Microbiol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.0105-2896.2006.00402.x","article-title":"Protective \u2018immunity\u2019 by pre-existent neutralizing antibody titers and preactivated T cells but not by so-called \u2018immunological memory\u2019.","volume":"211","author":"RM Zinkernagel","year":"2006","journal-title":"Immunol Rev"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4269\/ajtmh.1972.21.214","article-title":"A prospective study of serum antibody and protection against smallpox.","volume":"21","author":"TM Mack","year":"1972","journal-title":"Am J Trop Med Hyg"},{"key":"ref42","first-page":"307","article-title":"The minimum protective level of antibodies in smallpox.","volume":"52","author":"JK Sarkar","year":"1975","journal-title":"Bull World Health Organ"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1128\/JVI.01797-08","article-title":"Vaccinia virus extracellular enveloped virion neutralization in vitro and protection in vivo depend on complement.","volume":"83","author":"MR Benhnia","year":"2009","journal-title":"J Virol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"12921","DOI":"10.1073\/pnas.0505180102","article-title":"Interferon function is not required for recovery from a secondary poxvirus infection.","volume":"102","author":"V Panchanathan","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1086\/595565","article-title":"Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox.","volume":"199","author":"N Paran","year":"2009","journal-title":"J Infect Dis"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"13139","DOI":"10.1128\/JVI.79.20.13139-13149.2005","article-title":"An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus Challenge.","volume":"79","author":"G Yang","year":"2005","journal-title":"J Virol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0166-3542(03)00110-4","article-title":"Esterification of cidofovir with alkoxyalkanols increases oral bioavailability and diminishes drug accumulation in kidney.","volume":"59","author":"SL Ciesla","year":"2003","journal-title":"Antiviral Res"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1128\/AAC.00021-09","article-title":"Non-human primates are protected from smallpox virus or monkeypox virus challenges by the antiviral drug ST-246.","volume":"53","author":"J Huggins","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/med.20153","article-title":"Another ten stories in antiviral drug discovery (part C): \u201cOld\u201d and \u201cnew\u201d antivirals, strategies, and perspectives.","volume":"29","author":"E De Clercq","year":"2009","journal-title":"Med Res Rev"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1128\/AAC.01596-08","article-title":"ST-246(R) Antiviral Efficacy in a Non-Human Primate Monkeypox Model: Determination of the Minimal Effective Dose and Human Dose Justification.","volume":"53","author":"R Jordan","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.antiviral.2007.08.003","article-title":"Efficacy of therapeutic intervention with an oral ether-lipid analogue of cidofovir (CMX001) in a lethal mousepox model.","volume":"77","author":"S Parker","year":"2008","journal-title":"Antiviral Res"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1177\/135965350801300703","article-title":"Using biomarkers to stage disease progression in a lethal mousepox model treated with CMX001.","volume":"13","author":"S Parker","year":"2008","journal-title":"Antivir Ther"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1128\/AAC.00879-06","article-title":"Efficacy of delayed treatment with ST-246 given orally against systemic orthopoxvirus infections in mice.","volume":"51","author":"DC Quenelle","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.virol.2003.11.015","article-title":"Efficacy of oral active ether lipid analogs of cidofovir in a lethal mousepox model.","volume":"318","author":"RM Buller","year":"2004","journal-title":"Virology"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"12520","DOI":"10.1128\/JVI.01528-08","article-title":"Mechanism of antiviral drug resistance of vaccinia virus: identification of residues in the viral DNA polymerase conferring differential resistance to antipoxvirus drugs.","volume":"82","author":"DB Gammon","year":"2008","journal-title":"J Virol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1743-422X-5-58","article-title":"Isolation and characterization of cidofovir resistant vaccinia viruses.","volume":"5","author":"MN Becker","year":"2008","journal-title":"Virol J"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1128\/AAC.00380-06","article-title":"Mutations in the E9L polymerase gene of cidofovir-resistant vaccinia virus strain WR are associated with the drug resistance phenotype.","volume":"50","author":"RS Kornbluth","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"9391","DOI":"10.1128\/JVI.00605-06","article-title":"Cidofovir resistance in vaccinia virus is linked to diminished virulence in mice.","volume":"80","author":"G Andrei","year":"2006","journal-title":"J Virol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1128\/AAC.46.5.1329-1335.2002","article-title":"Characterization of wild-type and cidofovir-resistant strains of camelpox, cowpox, monkeypox, and vaccinia viruses.","volume":"46","author":"DF Smee","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"6829","DOI":"10.4049\/jimmunol.175.10.6829","article-title":"Antibodies and CD8+ T Cells Are Complementary and Essential for Natural Resistance to a Highly Lethal Cytopathic Virus.","volume":"175","author":"M Fang","year":"2005","journal-title":"J Immunol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"8027","DOI":"10.4049\/jimmunol.177.11.8027","article-title":"Direct CD28 Costimulation Is Required for CD8+ T Cell-Mediated Resistance to an Acute Viral Disease in a Natural Host.","volume":"177","author":"M Fang","year":"2006","journal-title":"J Immunol"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.virol.2005.09.056","article-title":"Immunization with a single extracellular enveloped virus protein produced in bacteria provides partial protection from a lethal orthopoxvirus infection in a natural host.","volume":"345","author":"M Fang","year":"2006","journal-title":"Virology"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1084\/jem.20082874","article-title":"A host type I interferon response is induced by cytosolic sensing of the bacterial second messenger cyclic-di-GMP.","volume":"206","author":"SM McWhirter","year":"2009","journal-title":"J Exp Med"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/978-1-60761-362-6_28","article-title":"Studying NK cell responses to ectromelia virus infections in mice.","volume":"612","author":"M Fang","year":"2010","journal-title":"Methods Mol Biol"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1006\/abio.1999.4085","article-title":"Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro.","volume":"270","author":"J Winer","year":"1999","journal-title":"Anal Biochem"}],"container-title":["PLoS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.ppat.1002475","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T05:42:04Z","timestamp":1686634924000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1002475"}},"subtitle":[],"editor":[{"given":"Michael S.","family":"Diamond","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,1,5]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2012,1,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1002475","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,5]]}}}